• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sorting Through the Risks and Benefits of Thiopurine Therapy for Inflammatory Bowel Diseases.

作者信息

Singh Harminder, Bernstein Charles N

机构信息

Inflammatory Bowel Disease Clinical and Research Centre, Department of Internal Medicine, University of Manitoba, Rady College of Medicine, Max Rady Faculty of Health Sciences, Winnipeg, Manitoba, Canada.

出版信息

Clin Gastroenterol Hepatol. 2019 Oct;17(11):2171-2172. doi: 10.1016/j.cgh.2019.04.047. Epub 2019 Apr 28.

DOI:10.1016/j.cgh.2019.04.047
PMID:31042576
Abstract
摘要

相似文献

1
Sorting Through the Risks and Benefits of Thiopurine Therapy for Inflammatory Bowel Diseases.梳理硫嘌呤类药物治疗炎症性肠病的风险与益处
Clin Gastroenterol Hepatol. 2019 Oct;17(11):2171-2172. doi: 10.1016/j.cgh.2019.04.047. Epub 2019 Apr 28.
2
Relevance of thiopurine methyltransferase activity in inflammatory bowel disease patients maintained on low-dose azathioprine.硫嘌呤甲基转移酶活性在接受低剂量硫唑嘌呤维持治疗的炎症性肠病患者中的相关性
Aliment Pharmacol Ther. 2002 Mar;16(3):389-98. doi: 10.1046/j.1365-2036.2002.01177.x.
3
Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease.硫嘌呤甲基转移酶基因型筛查在即将开始使用硫唑嘌呤治疗炎症性肠病患者中的成本效益分析
Aliment Pharmacol Ther. 2004 Sep 15;20(6):593-9. doi: 10.1111/j.1365-2036.2004.02124.x.
4
[Frequency of serious adverse events of thiopurine treatment in normal thiopurine S-methyltransferase genotype children with inflammatory bowel disease].[硫嘌呤甲基转移酶基因型正常的炎症性肠病儿童接受硫嘌呤治疗时严重不良事件的发生率]
Orv Hetil. 2019 Feb;160(5):179-185. doi: 10.1556/650.2019.31277.
5
Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.硫嘌呤甲基转移酶活性联合6-硫鸟嘌呤代谢物水平可预测炎症性肠病患者对硫嘌呤类药物的临床反应。
Dig Liver Dis. 2008 Jun;40(6):425-32. doi: 10.1016/j.dld.2008.01.003. Epub 2008 Mar 4.
6
Thiopurine therapy in inflammatory bowel disease.炎症性肠病的硫嘌呤治疗。
Expert Rev Gastroenterol Hepatol. 2010 Oct;4(5):575-88. doi: 10.1586/egh.10.59.
7
Allopurinol enhanced thiopurine treatment for inflammatory bowel disease: safety considerations and guidelines for use.别嘌醇增强硫嘌呤类药物治疗炎症性肠病的效果：安全性考量及使用指南
J Clin Pharm Ther. 2014 Apr;39(2):107-11. doi: 10.1111/jcpt.12125. Epub 2014 Jan 20.
8
Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease.综述文章：药物遗传学在改善炎症性肠病硫嘌呤治疗中的益处。
Aliment Pharmacol Ther. 2012 Jan;35(1):15-36. doi: 10.1111/j.1365-2036.2011.04905.x. Epub 2011 Nov 2.
9
Nonmelanoma Skin Cancer Risk in Patients With Inflammatory Bowel Disease Undergoing Thiopurine Therapy: A Systematic Review of the Literature.接受硫嘌呤治疗的炎症性肠病患者的非黑色素瘤皮肤癌风险：文献系统综述
Dermatol Surg. 2018 Apr;44(4):469-480. doi: 10.1097/DSS.0000000000001455.
10
Addition of Allopurinol for Altering Thiopurine Metabolism to Optimize Therapy in Patients with Inflammatory Bowel Disease.加用别嘌醇改变巯嘌呤代谢以优化炎症性肠病患者的治疗。
Pharmacotherapy. 2018 Feb;38(2):259-270. doi: 10.1002/phar.2067. Epub 2018 Jan 10.

引用本文的文献

1
The 2023 Impact of Inflammatory Bowel Disease in Canada: Cancer and IBD.2023年炎症性肠病在加拿大的影响：癌症与炎症性肠病
J Can Assoc Gastroenterol. 2023 Sep 5;6(Suppl 2):S83-S96. doi: 10.1093/jcag/gwad006. eCollection 2023 Sep.
2
Combination therapy is not associated with improved rates of clinical or endoscopic remission in patients with inflammatory bowel disease treated with ustekinumab or vedolizumab: a retrospective study.一项回顾性研究表明，对于接受优特克单抗或维多珠单抗治疗的炎症性肠病患者，联合治疗与临床或内镜缓解率的提高无关。
Ann Gastroenterol. 2023 Jul-Aug;36(4):430-436. doi: 10.20524/aog.2023.0808. Epub 2023 May 29.
3
Immunomodulators: still having a role?
免疫调节剂：仍在发挥作用？
Gastroenterol Rep (Oxf). 2022 Nov 8;10:goac061. doi: 10.1093/gastro/goac061. eCollection 2022.
4
The Evolving Role of Thiopurines in Inflammatory Bowel Disease.硫嘌呤类药物在炎症性肠病中不断演变的作用
Curr Treat Options Gastroenterol. 2019 Dec;17(4):435-448. doi: 10.1007/s11938-019-00249-y.
5
The Evolving Role of Thiopurines in Inflammatory Bowel Disease.硫嘌呤类药物在炎症性肠病中不断演变的作用
Curr Treat Options Gastroenterol. 2019 Sep;17(3):420-433. doi: 10.1007/s11938-019-00244-3.